Non-Antibiotic Selectable Markers for Biodefense (R21)
The summary for the Non-Antibiotic Selectable Markers for Biodefense (R21) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Non-Antibiotic Selectable Markers for Biodefense (R21): - To stimulate development of non-antibiotic selectable markers for bacteria of biodefense interest-FY 2006 total anticipated amount to be awarded: $3 million-The anticipated number of awards: 5-10-Mechanism: Exploratory/Developmental Research Project Grant (R21)-The total project period for an application submitted in response to this funding opportunity may not exceed two years. Direct costs are limited to $275,000 over an R21 two-year period, with no more than $200,000 in direct costs allowed in any single year.-Eligible organizations: For profit organizations; Non-profit organizations; Public or private institutions, such as universities, colleges, hospitals and laboratories; Units of State government; Units of local government; Eligible institutions of the Federal government; Domestic institutions; Foreign institutions; Faith-based or community-based organizations; Units of State Tribal government; and Units of Local Tribal government. -Eligible Project Directors/Principal Investigators (PD/PIs): Any individual with the skills, knowledge, and resources necessary to carry out the proposed research is invited to work with their institution to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH programs.-Applicants may submit more than one application, provided each application is scientifically distinct.
|Federal Grant Title:||Non-Antibiotic Selectable Markers for Biodefense (R21)|
|Federal Agency Name:||National Institutes of Health|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||RFA-AI-06-021|
|Type of Funding:||Grant|
|CFDA Descriptions:||Microbiology and Infectious Diseases Research|
|Current Application Deadline:||No deadline provided|
|Original Application Deadline:||Sep 13, 2006|
|Posted Date:||Apr 10, 2006|
|Creation Date:||Apr 10, 2006|
|Archive Date:||Oct 13, 2006|
|Total Program Funding:||$3,000,000|
|Maximum Federal Grant Award:||$200,000|
|Minimum Federal Grant Award:|
|Expected Number of Awards:|
|Cost Sharing or Matching:||No|
- Applicants Eligible for this Grant
- Public and State controlled institutions of higher education For profit organizations other than small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification) Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities County governments Independent school districts Native American tribal governments (Federally recognized) Special district governments Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments State governments
- Additional Information on Eligibility
- Foreign institutions are eligible to apply. Eligible agencies of the Federal Government are eligible to apply. Faith-based or community-based organizations
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
- Similar Government Grants
- • Biomedical Prevention of HIV Research Education (R25)
- • Partnerships for Next Generation Biodefense Diagnostics (R01)
- • National Biocontainment Laboratories (NBLs) Operations Support Limited Competition (UC7)
- • Partnerships for Development of New Therapeutic Classes for Select Viral and Bacterial Pat...
- • Partnerships to Improve Diagnosis and Treatment of Selected Drug-Resistant Healthcare-Asso...
- • Cooperative Research Partnerships for Biodefense (U01)
- • Pharmacological Approaches to Combating Antimicrobial Resistance (R01)
- More Grants from the National Institutes of Health
- • Limited Competition for NIH-Industry Program: Discovering Pediatric New Therapeutic Uses f...
- • Environmental influences on Placental Origins of Development (ePOD) (R01)
- • Limited Competition for NIH-Industry Program: Discovering New Therapeutic Uses for Existin...
- • Pre-application for the NIH-Industry Program: Discovering New Therapeutic Uses for Existin...
- • Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R01)